We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
- Authors
Morschhauser, Franck; Radford, John; Van Hoof, Achiel; Vitolo, Umberto; Soubeyran, Pierre; Tilly, Herve; Huijgens, Peter C; Kolstad, Arne; d'Amore, Francesco; Gonzalez Diaz, Marcos; Petrini, Mario; Sebban, Catherine; Zinzani, Pier Luigi; van Oers, Marinus H J; van Putten, Wim; Bischof-Delaloye, Angelika; Rohatiner, Ama; Salles, Gilles; Kuhlmann, Jens; Hagenbeek, Anton
- Abstract
We conducted an international, randomized, phase III trial to evaluate the efficacy and safety of consolidation with yttrium-90 ((90)Y)-ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma in first remission.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 32, p5156
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.17.2015